1/28
10:12 am
maze
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/16
12:23 pm
maze
Rating for MAZE
Low
Report
Rating for MAZE
12/19
09:09 am
maze
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/19
09:09 am
maze
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/9
08:11 am
maze
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Low
Report
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
12/4
08:36 am
maze
Rating for MAZE
Low
Report
Rating for MAZE
12/4
08:36 am
maze
Rating for MAZE
Low
Report
Rating for MAZE
12/4
05:32 am
maze
Maze Therapeutics initiated with an Overweight at Wells Fargo
Low
Report
Maze Therapeutics initiated with an Overweight at Wells Fargo
12/4
05:32 am
maze
Maze Therapeutics initiated with an Overweight at Wells Fargo
Low
Report
Maze Therapeutics initiated with an Overweight at Wells Fargo
12/3
10:09 am
maze
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.